These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 22969587)

  • 41. (E)-1-{4-[Bis(4-meth-oxy-phen-yl)meth-yl]piperazin-1-yl}-3-(4-methyl-phen-yl)prop-2-en-1-one.
    Zhong Y; Wu B
    Acta Crystallogr Sect E Struct Rep Online; 2011 Oct; 67(Pt 10):o2791. PubMed ID: 22064692
    [TBL] [Abstract][Full Text] [Related]  

  • 42. (E)-1-{4-[Bis(4-meth-oxy-phen-yl)meth-yl]piperazin-1-yl}-3-(4-fluoro-phen-yl)prop-2-en-1-one.
    Teng YB; Dai ZH; Wu B
    Acta Crystallogr Sect E Struct Rep Online; 2011 Feb; 67(Pt 3):o697. PubMed ID: 21522442
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 4-(4-Chloro-phen-yl)-4-hy-droxy-piperidinium benzoate.
    Jasinski JP; Golen JA; Siddaraju BP; Dayananda AS; Yathirajan HS
    Acta Crystallogr Sect E Struct Rep Online; 2011 Jun; 67(Pt 6):o1436. PubMed ID: 21754814
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Crystal structure of [4-(chloro-meth-yl)phen-yl](4-hy-droxy-piperidin-1-yl)methanone.
    Revathi BK; Reuben Jonathan D; Kalai Sevi K; Dhanalakshmi K; Usha G
    Acta Crystallogr E Crystallogr Commun; 2015 Oct; 71(Pt 10):o703-4. PubMed ID: 26594432
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Crystal structure, Hirshfeld surface analysis and computational study of the 1:2 co-crystal formed between
    Tan SL; Tiekink ERT
    Acta Crystallogr E Crystallogr Commun; 2020 Jun; 76(Pt 6):870-876. PubMed ID: 32523755
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 1-(4-Chloro-benzo-yl)-3-(2,4,6-trichloro-phen-yl)thio-urea hemihydrate.
    Khawar Rauf M; Bolte M; Badshah A
    Acta Crystallogr Sect E Struct Rep Online; 2008 Dec; 65(Pt 1):o143. PubMed ID: 21581602
    [TBL] [Abstract][Full Text] [Related]  

  • 47. (E)-1-{4-[Bis(4-bromo-phen-yl)meth-yl]piperazin-1-yl}-3-(4-eth-oxy-3-meth-oxy-phen-yl)prop-2-en-1-one.
    Zhong Y; Zhang X; Wu B
    Acta Crystallogr Sect E Struct Rep Online; 2012 Jan; 68(Pt 1):o122. PubMed ID: 22259410
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 2-[2-Chloro-5-(trifluoro-methyl)-phen-yl]hexa-hydro-pyrimidine monohydrate.
    Fun HK; Kia R
    Acta Crystallogr Sect E Struct Rep Online; 2008 Aug; 64(Pt 9):o1840-1. PubMed ID: 21201812
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 1-(4-Chloro-phen-yl)-2-[4-hy-droxy-3-(3-meth-oxy-benzo-yl)-1,1-dioxo-2H-1λ(6),2-benzothia-zin-2-yl]ethanone.
    Siddiqui HL; Ahmad M; Gul S; Ashraf CM; Parvez M
    Acta Crystallogr Sect E Struct Rep Online; 2012 Apr; 68(Pt 4):o1058-9. PubMed ID: 22589926
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tetra-aqua-bis-(N,N-dimethyl-formamide-κO)zinc(II) bis-[(2-{3-[2-(carboxyl-ato-meth-oxy-κ(2)O,O')phen-yl]pyrazol-1-yl-κN(2)}acetato-κO)chloridozincate(II)].
    Yang J; Shen L; Ji C; Shen XF; Yang GW
    Acta Crystallogr Sect E Struct Rep Online; 2012 Jun; 68(Pt 6):m817. PubMed ID: 22719360
    [TBL] [Abstract][Full Text] [Related]  

  • 51. N-{2-[4-(2-Meth-oxy-phen-yl)piperazin-1-yl]eth-yl}pyridin-2-amine monohydrate.
    Jiang QF; Lu CX
    Acta Crystallogr Sect E Struct Rep Online; 2010 Jun; 66(Pt 7):o1727. PubMed ID: 21587944
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diethyl [(5-chloro-2-hydroxy-anilino)(4-chloro-phen-yl)meth-yl]phospho-nate.
    Krishnaiah M; Surendra Babu VH; Syam Prasad G; Suresh Reddy C; Puranik VG
    Acta Crystallogr Sect E Struct Rep Online; 2009 Sep; 65(Pt 10):o2506-7. PubMed ID: 21577955
    [TBL] [Abstract][Full Text] [Related]  

  • 53. (Z)-1-(2-Chloro-phen-yl)-3-methyl-4-[2-(4-nitro-phen-yl)hydrazin-1-yl-idene]-1H-pyrazol-5(4H)-one.
    Bustos C; Escobar-Fuentealba A; Alvarez-Thon L; Faundez-Gutierrez R; Garland MT
    Acta Crystallogr Sect E Struct Rep Online; 2012 Aug; 68(Pt 8):o2351-2. PubMed ID: 22904819
    [TBL] [Abstract][Full Text] [Related]  

  • 54. (E)-1-{4-[Bis(4-bromo-phen-yl)meth-yl]piperazin-1-yl}-3-(4-bromo-phen-yl)prop-2-en-1-one.
    Zhong Y; Zhang X; Wu B
    Acta Crystallogr Sect E Struct Rep Online; 2011 Dec; 67(Pt 12):o3358. PubMed ID: 22199852
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 1-(2,3-Di-methyl-phen-yl)piperazine-1,4-diium tetra-chlorido-cuprate(II).
    Ben Mabrouk S; Ameur I; Abid S; Rzaigui M
    Acta Crystallogr Sect E Struct Rep Online; 2013; 69(Pt 9):m485. PubMed ID: 24426985
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fifteen 4-(2-meth-oxy-phen-yl)piperazin-1-ium salts containing organic anions: supra-molecular assembly in zero, one, two and three dimensions.
    Harish Chinthal C; Kavitha CN; Yathirajan HS; Foro S; Rathore RS; Glidewell C
    Acta Crystallogr E Crystallogr Commun; 2020 Nov; 76(Pt 11):1779-1793. PubMed ID: 33209353
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diethyl 2,6-dihy-droxy-4-(3-nitro-phen-yl)-2,6-bis-(trifluoro-meth-yl)piperidine-3,5-dicarboxyl-ate.
    Fun HK; Arshad S; Reddy BP; Vijayakumar V; Sarveswari S
    Acta Crystallogr Sect E Struct Rep Online; 2012 Feb; 68(Pt 2):o400-1. PubMed ID: 22347021
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 4-{2-[2-(4-Chloro-benzyl-idene)hydrazinyl-idene]-3,6-dihydro-2H-1,3,4-thia-diazin-5-yl}-3-(4-meth-oxy-phen-yl)sydnone.
    Fun HK; Loh WS; Nithinchandra ; Kalluraya B
    Acta Crystallogr Sect E Struct Rep Online; 2011 May; 67(Pt 5):o1175-6. PubMed ID: 21754480
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Crystal structure of 2-[4(E)-2,6-bis-(4-chloro-phen-yl)-3-ethyl-piperidin-4-yl-idene]acetamide.
    Priya K; Saravanan K; Selvanayagam S; Kabilan S
    Acta Crystallogr E Crystallogr Commun; 2015 Nov; 71(Pt 11):o832-3. PubMed ID: 26594551
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Crystal structures of the recreational drug
    Kiran Kumar H; Yathirajan HS; Harish Chinthal C; Foro S; Glidewell C
    Acta Crystallogr E Crystallogr Commun; 2020 Apr; 76(Pt 4):488-495. PubMed ID: 32280490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.